Amylyx Pharmaceuticals - AMLX Operatsion rentabellik

Amylyx Pharmaceuticals, Inc. - AMLX emitenti grafik logotipi

GURU.Markets platformasidagi asosiy biznes marjasi ko'rsatkichi foyda dinamikasini aks ettiradi, bunda 0.00 joriy metrika qiymatini tashkil etadi. Amylyx Pharmaceuticals (AMLX) noyob formulalar tufayli neyroproteksiya segmentida narxlarni belgilash imkoniyatiga ega. Dori vositalarini yetkazib berish qat'iy harorat nazoratiga bog'liq bo'lib, bu xarajatlarni oshiradi. Rahbariyat hozirda ishchi kuchidagi beqarorlik fonida asosiy R&D mutaxassislarini saqlab qolishga e'tibor qaratmoqda.

AMLX: amylyx.com Operatsion marja 04.07.2022 - 19.11.2026

Amylyx Pharmaceuticals, Inc. (AMLX) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning asosiy tahlili:Amylyx Pharmaceuticals, Inc.
amylyx.com tayyor mahsulotlari

Operatsion marja operatsion foydaning kompaniyaning umumiy daromadiga nisbati sifatida hisoblanadi. Ushbu metrika qarz majburiyatlari va soliqlarni hisobga olguncha, asosiy biznes doirasidagi xarajatlarni boshqarish samaradorligini belgilaydi. Amylyx Pharmaceuticals (AMLX) uchun ushbu ko'rsatkich kamyob neyrodegenerativ kasalliklarni davolash uchun dori vositalarini ishlab chiqish xarajatlarini aks ettiradi. Yuqori talabga ega bo'lgan nishalarda portfel diversifikatsiyasi xarajatlar dinamikasiga bevosita ta'sir ko'rsatadi. Operatsion foyda marjasini tahlil qilish orqali investor emitentning fundamental modelining barqarorligini baholaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

Sotuvning operatsion marjasi BIIB|NBIX: Operatsion foyda normasi|Operatsion rentabellik Regencell Bioscience Ltd (RGC)|Operatsion marja axsome.com (AXSM)|Operatsion marja ACAD (acadia-pharm.com)|XENE - Sotuvning operatsion marjasi|vikingtherapeutics.com - Operatsion marja|Supernus Pharma (SUPN) - Sotuvning operatsion marjasi|CPRX: Operatsion marja|Denali Therapeutics Inc. (DNLI) - Operatsion marja|Operatsion rentabellik Harmony Pharma|Operatsion rentabellik BHVN|Operatsion marja TRVI|PRAX (Praxis Corp) - Operatsion foyda normasi|Operatsion marja AVXL (anavex.com)|CBLL: Operatsion foyda bo'yicha sotuv rentabelligi|PRTA - Operatsion rentabellik|ALEC - Operatsion marja|Annexon Inc. (ANNX) - Operatsion rentabellik|Sotuvning operatsion marjasi Omeros Corp|Sotuvning operatsion marjasi NGNE|ACIU: Operatsion foyda normasi|Sotuvning operatsion marjasi VYGR (Voyager Corp)|Sotuvning operatsion marjasi Neumora NMRA|Operatsion rentabellik Scilex Holding Company, Inc. SCLX|Operatsion foyda bo'yicha marjinallik Tevogen Bio Inc.|ACOG - Operatsion rentabellik|Operatsion foyda bo'yicha marjinallik Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Sotuvning operatsion marjasi|Cassava Sciences Inc (SAVA) - Operatsion marja|Sotuvning operatsion marjasi ASRT|Operatsion marja coyatherapeutics.com|Operatsion marja VTGN|Ovid Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Sotuvning operatsion marjasi|ATHE - Operatsion rentabellik|Operatsion faoliyat rentabelligi clene.com CLNN|PEPG: Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi JUNS|RLMD (Relmada Corp) - Operatsion marja|Annovis Bio Inc (ANVS) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Operatsion foyda normasi|Operatsion rentabellik Klotho Neurosciences KLTO|NRSN: Operatsion foyda bo'yicha sotuv rentabelligi|RVPH: Sotuvning operatsion marjasi|MTVA: Operatsion rentabellik|NRXS (NeurAxis Inc) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi Helius Medical Technologies, Inc.|Operatsion rentabellik Passage Bio Inc.|Sotuvning operatsion rentabelligi bionomics.com.au NEUP|Operatsion marja NERV|Operatsion marja Athira Pharma Inc (ATHA)|Operatsion marja ADXN (Addex Therapeutics Ltd.)|ALZN: Operatsion foyda bo'yicha sotuv rentabelligi|CYCN - Operatsion rentabellik|Sotuvning operatsion rentabelligi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha marjinallik Cortigent, Inc. CRGT|Operatsion rentabellik Avenue Therapeutics, Inc.|Sotuvning operatsion marjasi BrainStorm Cell Therapeutics Inc. (BCLI)|Operatsion rentabellik Cara Therapeutics, Inc (CARA)|Operatsion rentabellik CHRO (Chromocell Therapeutics Corp.)|Operatsion marja ELYM (eliemtx.com)|intracellulartherapies.com - Operatsion rentabellik|LBPH: Sotuvning operatsion marjasi|Operatsion foyda normasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Sotuvning operatsion marjasi|Sotuvning operatsion marjasi NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operatsion marja|Neurotrope - Operatsion foyda marjasi|Operatsion marja TRVN|Operatsion faoliyat rentabelligi Vigil Neuroscience, Inc.|Operatsion rentabellik Anew Medical, Inc. WENA|CERE - Sotuvning operatsion marjasi